CME America Recalls BodyGuard Microset Infusion Sets Due to Delivery Inaccuracy
CME America, LLC is recalling BodyGuard Microset infusion administration sets because they may deliver therapy with an inaccuracy exceeding plus/minus 13%, potentially causing over- or under-infusion.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is FDA Class I, which per the rubric mandates a score of at least 4. However, the source text explicitly states no illnesses or injuries have been reported and the hazard is theoretical (risk of over/under-infusion), which caps the score at 3 according to the rule: 'If the source text explicitly states no illnesses/injuries reported and the hazard is theoretical, the score is at most 3.'
Plain-English summary
CME America, LLC has issued a recall for the BodyGuard Microset (REF: A120-160XPS), an infusion administration set. The company is recalling 479,559 units because the devices may have a delivery inaccuracy ranging from minus 42.8% to plus 17.5%, which exceeds the acceptable limit of plus/minus 13%. This defect could result in the over-infusion or under-infusion of therapy when used with an infusion pump system.
The recall affects all lots within their expiry date. The products were distributed across the United States, including California, Indiana, Louisiana, Missouri, Florida, Illinois, Maine, Minnesota, Colorado, Virginia, Oklahoma, Nebraska, Georgia, Alabama, Kentucky, Iowa, Mississippi, Idaho, Texas, South Carolina, Ohio, South Dakota, Nevada, Michigan, Wyoming, North Carolina, Pennsylvania, Tennessee, Kansas, New Jersey, Oregon, Arkansas, New Mexico, Massachusetts, New York, Washington D.C., Rhode Island, Maryland, Washington, Wisconsin, Arizona, New Hampshire, Utah, Hawaii, Alaska, Montana, North Dakota, Vermont, and Connecticut. The products were also distributed in foreign markets, specifically Canada and the United Kingdom.
Consumers who possess this product should stop using it immediately and contact CME America, LLC for further instructions regarding returns or replacements.
The recalled product
- Product
- BodyGuard Microset, REF: A120-160XPS
- Manufacturer
- CME America, LLC
- Affected units
- 479,559
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry date
Distribution
Part of a larger recall action
This product is one of 37 recalled by CME America, LLC under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · CME America, LLC
See all →- SevereCME America Recalls NeoThrive Syringe Pumps Due to Motor Wear
FDA (Devices) · 2020-12-09
- HighCME America T-Syringe Pump Recalled for Motor Wear and Hardware Damage
FDA (Devices) · 2020-12-09
- HighCME America T-Syringe Pump T34 Recalled for Motor Wear and Hardware Cracks
FDA (Devices) · 2020-12-09
- HighCME America Recalls Neofeed Syringe Pumps Due to Motor Wear and Cracks
FDA (Devices) · 2020-12-09
- SevereCME America T-Syringe Pump Recall for Motor Wear and Fluid Damage
FDA (Devices) · 2020-12-09
Same hazard · delivery inaccuracy
See all →- HighAlung Technologies Recalls Hemolung Respiratory Assist System Infusion Pumps
FDA (Devices) · 2021-02-10
- SevereCME BodyGuard Microset Infusion Sets Recalled for Delivery Inaccuracy
FDA (Devices) · 2020-07-22
- SevereCME America BodyGuard Microset Infusion Sets Recalled for Delivery Inaccuracy
FDA (Devices) · 2020-07-22
- SevereCME BodyGuard Microset Infusion Sets Recalled for Delivery Inaccuracy
FDA (Devices) · 2020-07-22
- SevereCME America Recalls CMExpress Microbore Sets Due to Delivery Inaccuracy
FDA (Devices) · 2020-07-22